Cargando…
Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy
Background: we aimed to assess the influence of metabolic syndrome on fibrosis regression (using liver-stiffness measurement (LSM) and serological scores) and the relationship with the expression of lysyl oxidase-like-2 as a potential goal of antifibrotic therapy. Methods: We included 271 patients t...
Autores principales: | Puente, Angela, Fortea, Jose Ignacio, Posadas, Miguel, Garcia Blanco, Agustin, Rasines, Laura, Cabezas, Joaquin, Arias Loste, Maria Teresa, Llerena, Susana, Iruzubieta, Paula, Fábrega, Emilio, Crespo, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723423/ https://www.ncbi.nlm.nih.gov/pubmed/31426495 http://dx.doi.org/10.3390/jcm8081242 |
Ejemplares similares
-
LOXL2—A New Target in Antifibrogenic Therapy?
por: Puente, Angela, et al.
Publicado: (2019) -
Lysyl oxidase–like 2 (LOXL2)–mediated cross-linking of tropoelastin
por: Schmelzer, Christian E. H., et al.
Publicado: (2019) -
Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It
por: Puente, Angela, et al.
Publicado: (2019) -
Impact of an acute hemodynamic response-guided protocol for primary prophylaxis of variceal bleeding
por: Fortea, José Ignacio, et al.
Publicado: (2018) -
Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state
por: Zhang, Xi, et al.
Publicado: (2018)